07:00 , Sep 10, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Pulmonary disease Asthma; chronic obstructive pulmonary disease (COPD) Muscarinic acetylcholine receptor M3 (CHRM3; HM3) Studies in mice identified a tropane-based CHRM3 antagonist that could help...